Topiramate labels and packages

Topiramate
TOPIRAMATE^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Topiramate
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information about topiramate, click here.

Labels and Packages

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 25 mg (60 Tablet Bottle)

NDC 65862-171-60 Topiramate Tablets USP 25 mg PHARMACIST: PLEASE DISPENSE WITH MEDICATION GUIDE PROVIDED SEPARATELY Rx only 60 Tablets AUROBINDO

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 50 mg (60 Tablet Bottle)

NDC 65862-172-60 Topiramate Tablets USP 50 mg PHARMACIST: PLEASE DISPENSE WITH MEDICATION GUIDE PROVIDED SEPARATELY Rx only 60 Tablets AUROBINDO

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 100 mg (60 Tablet Bottle)

NDC 65862-173-60 Topiramate Tablets USP 100 mg PHARMACIST: PLEASE DISPENSE WITH MEDICATION GUIDE PROVIDED SEPARATELY Rx only 60 Tablets AUROBINDO

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 200 mg (60 Tablet Bottle)

NDC 65862-174-60 Topiramate Tablets USP 200 mg PHARMACIST: PLEASE DISPENSE WITH MEDICATION GUIDE PROVIDED SEPARATELY Rx only 60 Tablets AUROBINDO

Adapted from the FDA Package Insert.